Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke
Post-Market Registry on Use of Merci Retrieval System. Primary data to be collected will include:
- Post-procedure revascularization success
- 90-day mRS 0-2
- 90-day mortality
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke|
- Post-procedure revascularization success [ Time Frame: post-procedure ]
- NIHSS change from baseline to 24-hours [ Time Frame: 24-hour ]
- 90-day mRS outcomes [ Time Frame: 90-day ]
- 90-day mortality [ Time Frame: 90-day ]
|Study Start Date:||June 2007|
|Study Completion Date:||September 2010|
|Primary Completion Date:||May 2010 (Final data collection date for primary outcome measure)|
Acute Ischemic Stroke patients
Patients presenting with signs and symptoms consistent with a diagnosis of Acute Ischemic Stroke, who are treated with the Merci Retrieval System during a Mechanical Thrombectomy procedure.
Procedure: Mechanical Thrombectomy
Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.
Other Name: Merci Retrieval System
The Merci Registry is a prospective multicenter registry with up to 3000 patients enrolled at a maximum of 100 sites.
The registry requires use (at least one pass in the intracranial vasculature) of any Merci Retriever device (X Series, L Series, V Series) in the setting of acute ischemic stroke due to large vessel intracranial occlusion.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00478478
|United States, Missouri|
|St. Luke's Brain and Stroke Institute|
|Kansas City, Missouri, United States, 64111|
|Principal Investigator:||Wade S Smith, MD, PhD||University of California at San Francisco, SF, CA|
|Principal Investigator:||Marilyn M Rymer, MD||MABSI St. Luke's, Kansas City, MO|